For the Inventor, By the Inventor

Enter assignee name

Branford, CT, United States of America

Isoplexis Corporation

USPTO Granted Patents = 20

% Expired Patents = 10.0

EPO Patents = 3

Trademarks = 9

Forward Citations = 33

Loading Chart...

Loading Chart...

37 inventors (with patents filed for the assignee):

Patrick Paczkowski (9 out of 9 patents)

Sean MacKay (8 out of 8 patents)

Jerzy Olejnik (6 out of 84 patents)

4. Sean McCusker (5 out of 10 patents)

5. Colin Ng (5 out of 5 patents)

6. Mong Sano Marma (4 out of 9 patents)

7. Alaina Kaiser (4 out of 4 patents)

8. Luisa Andruzzi (3 out of 5 patents)

9. Dona Hevroni (3 out of 4 patents)

10. Angela DeLucia (3 out of 4 patents)

11. Igor Nikonorov (3 out of 11 patents)

12. Emily Bettini (3 out of 3 patents)

13. Peter Tsiomplikas (3 out of 3 patents)

14. Steven Jeffrey Gordon (3 out of 37 patents)

15. Michel Georges Perbost (2 out of 5 patents)

20 patents: Sort by Forward Citations

1. 12643103 - Systems, devices and methods for multiplexed analysis (2026-06-02),

2. 12504378 - Systems, devices and methods for cell capture and methods of manufacture thereof (2025-12-23),

3. 12259392 - System and methods for multiplexed analysis of cellular and other immunotherapeutics (2025-03-25),

4. 12227798 - Methods and compositions for incorporating nucleotides (2025-02-18),

5. 12180531 - Analysis and screening of cell secretion profiles (2024-12-31),

6. 12139748 - Compositions and methods for the simultaneous genomic, transcriptomic and proteomic analysis of single cells (2024-11-12),

7. 11940413 - Methods and devices for sequencing nucleic acids in smaller batches (2024-03-26),

8. 11866741 - Polymerase enzyme from 9°N (2024-01-09),

9. 11821032 - DNA sequencing reaction additive (2023-11-21),

10. 11661619 - Analysis and screening of cell secretion profiles (2023-05-30),

11. 11548909 - Methods of using nucleotide analogues (2023-01-10),

12. 11525783 - Systems, devices and methods for cell capture and methods of manufacture thereof (2022-12-13),

13. 11493508 - Compositions and methods for the simultaneous genomic, transcriptomic and proteomic analysis of single cells (2022-11-08),

14. 11421264 - Thiol-containing cleave reagents and oxidative wash (2022-08-23),

15. 11162129 - Photoprotective mixtures as imaging reagents in sequencing-by-synthesis (2021-11-02),

IsoPlexis Corporation is a biotechnology company that specializes in developing and commercializing single-cell proteomics platform solutions. Their innovative technology enables researchers and clinicians to better understand complex biological systems and facilitate precise disease monitoring and drug development. With their high-performance proteomics systems, IsoPlexis empowers scientists to identify functional cellular subsets and biomarkers to improve patient outcomes. To learn more about IsoPlexis and their cutting-edge solutions, please visit their official website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Isoplexis Corporation

20 Patents

#8 in Branford, CT

#396 in Connecticut

#16,359 in US

#31,162 in the World

Branford, CT, United States of America

Isoplexis Corporation

Forward Citations = 33

37 inventors:

Patrick Paczkowski (9 out of 9 patents)

Sean MacKay (8 out of 8 patents)

Jerzy Olejnik (6 out of 84 patents)

4. Sean McCusker (5 out of 10 patents)

5. Colin Ng (5 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…